|
- Patients should not use immunoaugmentative therapy (IAT) in place of other, more established medical treatments for cancer.
- Proponents of IAT claim that it is safe and nontoxic. However, studied have not been performed to determine the safety of this therapy.
- Some healthcare professionals are concerned that infectious diseases, such as HIV and hepatitis, may contaminate the unregulated compounds used during IAT that are derived from human blood. Although there were reports of patients who acquired infections after IAT in the 1980s, no similar reports have been made since.
- There have been anecdotal reports of side effects, including fatigue, flu–like illness, pain at the injection site, generalized pain, and swelling caused by fluid accumulation.
|